Content uploaded by Lawson Ekpe
Author content
All content in this area was uploaded by Lawson Ekpe on Sep 27, 2018
Content may be subject to copyright.
JOURNAL OF MOLECULAR PATHOPHYSIOLOGY, 2018
VOL 7, NO. 1, PAGE 1–6
10.5455/jmp.20180627120817
REVIEW ARTICLE Open Access
Anoxidant eects of astaxanthin in various diseases—a review
Lawson Ekpe1, Kenneth Inaku1, Victor Ekpe2
1Department of Chemical Pathology, University of Calabar, Calabar, Nigeria
2Drexel University, Philadelphia, PA
Contact Lawson Ekpe lawsonekpe2002@yahoo.com Department of Chemical Pathology, University of Calabar, Calabar, Nigeria.
© 2018 The Authors. This is an open access arcle under the CC BY license (hps://creavecommons.org/licenses/by/4.0/).
ABSTRACT
Background: Astaxanthin, a potent anoxidant carotenoid has been found to be highly
eecve in mopping up free radicals as it possesses an-oxidave, an-inammatory,
an-apoptoc, and other benecial pharmacological properes. Many chemical reac-
ons produce free radicals which are injurious to body cells, as they are the causes of
many diseases, disabilies, and death. Anoxidants suppress and mop up these circulat-
ing free radicals.
Method: This review was done by a comprehensive literature search using internet
search engines linked to academics such as EBSCO, PubMed, Google Scholar, etc. They
were assessed on topics related to astaxanthin. Arcles related and linked to studies
involving astaxanthin were thoroughly searched and the references of such arcles were
also searched for informaon about astaxanthin in relaon to the medical applicaon.
Results: In various studies, astaxanthin has been found to be a potent carotenoid as an
anoxidant thereby protecve to the body as it prevents cancer, enhances eye health,
suppresses lipid peroxidaon and atherosclerosis, enhances skin and brain health, and
suppresses the formaon of complicaons of diabetes mellitus.
Conclusion: Astaxanthin, a highly potent xanthophylls carotenoid has mulple pharma-
cological properes, and oral supplements of this an-oxidant are protecve against a
wide range of diseases.
ARTICLE HISTORY
Received June 27, 2018
Accepted August 20, 2018
Published September 26, 2018
KEYWORDS
Astaxanthin; free radical;
anoxidant; cancer;
carotenoids
Introducon
Free radicals
Free radicals are molecules containing one or
more unpaired electrons which give a consid-
erable degree of chemical reactivity to it [1,2].
Most of these free radicals come from intracellu-
-
ids. The plasma membranes of cells are potential
sources of free radicals [3,4]. Other ways of free
radical generation are exposure to ionizing radi-
ation, cigarette smoking, sunlight, drug inges-
tion, and exposure of red blood cells to chemicals
such as acetyl phenylhydrazine and hydrogen
peroxide (H2O2) [5]. Exposure of some neonates
to oxidants such as dusting powder and camphor
balls results in increased hemolysis due to the
generation of free radicals [6]. Free radicals are
injurious to body cells and tissues and need to be
mopped up by antioxidants. Various sources of
antioxidants exist such as vitamins C and E and
glutathione. Astaxanthin is considered a potent
antioxidant.
Anoxidants
Antioxidants are protective against free radicals
such that the possible detrimental effects of these
free radicals that are generated are kept on check.
Hence, antioxidants stabilize free radicals’ reac-
tion. Some antioxidants may be enzymes such as
glutathione reductase, superoxide dismutase, and
catalase [7]. Dietary antioxidants also exist such as
vitamins A, C, E, and beta-carotene. Generally, anti-
oxidants are divided into two major groups:
Water soluble (hydrophilic)
cell cytosol and blood plasma. Examples of such are
vitamin C, glutathione, and catechins.
2 J Mol Pathophysiol • 2018 • Vol 7 • Issue 1
Lawson Ekpe, Kenneth Inaku, Victor Ekpe
Lipid soluble (hydrophobic)
They are localized to cellular membranes and
lipoproteins. These include vitamins A, E, and
beta-carotene [5,8]. Generally, antioxidants are
helpful in preventing or delaying cell damage as
they mop up free radicals generated from cellular
processes. Several antioxidants have been evalu-
ated such as vitamin C (ascorbic acid), vitamin E
(tocopherol), beta-carotene, selenium, lycopene,
and astaxanthin [8,9].
Astaxanthin
Astaxanthin is a lipophilic terpene which is made
up of carbon precursors [10,11]. It is a metabolite of
zeaxanthin and canthaxanthin, containing hydroxyl
and ketone functional groups [10,11]. Astaxanthin,
being a xanthophyll carotenoid is chemically identi-
lipid soluble and distinguished from all other carot-
enoids and has a molecular mass of 596.84 g/mol
with a formula of C40H52O4. It has conjugated dou-
ble bonds at its center—giving it, its antioxidant
effects [10,12].
Humans cannot synthesize astaxanthin in the
body [13]. Historically, Professor Basil Weedon’s
-
anthin by synthesis in 1970 [14]. Like all other
carotenoids, astaxanthin is absorbed alongside
fatty acids via passive diffusion into the intestinal
epithelium [15]. Sources of astaxanthin are yeasts,
Astaxanthin is present in most red-colored aquatic
organisms [13,15]. The primary sources of astax-
anthin in high concentrations are given below in
Table 1 [10].
Algae are the primary natural sources of astaxan-
thin in the aquatic food chain. The primary industrial
sources for natural astaxanthin are the microalgae
and Haematococcus pluvialis. Commercial astaxan-
thin for aquaculture is produced synthetically [10].
Historical Evolvement of Astaxanthin in
Medical Uses
Since its discovery in 1970, astaxanthin has evolved
through some technological processes to be use-
ful in everyday life uses. It is now mainly extracted
from Haematococcus pluvialis using high-pressure
spectrometry [16]. Currently, astaxanthin has
been approved as a food colorant in animal and
made by scientists to synthetically produce the
products of Haematococcus pluvialis. Lee et al. [18]
demonstrated that adding 1-aminocyclopropane-1-
carboxylic acid could enhance the accumulation of
astaxanthin while Shang et al. [19] suggested that
synthetic Haematococcus pluvialis production is
enhanced by using butylated hydroxyanisole.
Consumption of astaxanthin can reduce and
prevent various disorders in human and animals.
Synthetic astaxanthin has a dominant role in agri-
culture. The consumption of astaxanthin can reduce
or prevent the risk of various disorders in human
and animals. Synthetic astaxanthin is produced by
H. pluvialis through chemical syn-
thesis [20].
Mechanism of Acon of Astaxanthin
Usually, carotenoids are absorbed into body lipids
which are enhanced by high cholesterol. On absorp-
tion, astaxanthin mixes with bile acid to make
micelles and are incorporated into chylomicron.
Astaxanthin is then assimilated with lipoprotein
and transported to body tissues to protect cells such
as skin and lipid-based membrane against oxida-
tive damage [21]. Also, astaxanthin contains poly-
ene chain and multiple double bonds which quench
singlet oxygen and radicals to stop the reaction.
Antioxidant properties have been linked to their
chemical and physical interactions with cell mem-
branes. The polyene chain in astaxanthin mops up
free radicals in the cell membrane [22].
Review of Medical Uses of Astaxanthin
Over 50 clinical and experimental studies show
that astaxanthin is important in cardiovascular
health, eye health, brain health, sports-related
activities, skin health, diabetes mellitus and met-
abolic syndrome, cancer health, and a whole lot
of other disease entities [23,24]. In general, with
regards to general antioxidant effects (free radi-
cal scavenging), astaxanthin is more than 65 times
Table 1. Showing the sources of astaxanthin.
Natural sources Concentraon of astaxanthin
(Parts per million)
Salmonids 5
Plankton 60
Krill 120
Arcc shrimp (P. borealis)1,200
Phaa yeast
(Xanthophyllomyces
dendrorhous)
10,000
Haematococcus pluvialis 40,000
www.jmolpat.com 3
Astaxanthin as an anoxidant
stronger than vitamin C and 50 times more power-
ful than vitamin E in protecting cell membranes. In
addition, astaxanthin has been shown to be more
effective than other carotenoids and other nutri-
ents at singlet oxygen quenching by being up to
800 times stronger than coenzyme Q, 6,000 times
greater than vitamin C, 550 times more powerful
than green tea catechins, and 11 times stronger
than beta-carotene. It is also found to be 2.75 times
stronger than lutein [25]. Research suggests that
-
matory, and neurodegenerative diseases [26,27].
Astaxanthin has been shown to play a role in sev-
eral diseases.
Cancer prevenon
Several research studies have deciphered that
astaxanthin exerts in activity such as anti-
proliferation, anti-apoptosis, and anti-invasion
via different molecules and pathways including
signal transducers and activator of transcrip-
tion 3 (STAT 3), nuclear factor kappa light chain
proliferator activator receptor gamma, and other
multiple mechanism of cancer effects. According
to Zhang et al., astaxanthin is thought to pro-
tect body tissues from oxidation and ultraviolet
-
vation [28,29]. Astaxanthin also prevents can-
UV oxidant damage. It does this by promoting
early detection and destruction of cells that have
undergone malignant transformation by avoiding
immune surveillance [30,31]. Also, Jacobsson et al.
-
vents the tumor from spreading by reducing tumor
production of tissue-melting proteins and blocks
the rapid cell replication of tumors in their growth
phase by stopping the cancer cell reproductive
cycle and enhancing apoptosis [13,32,33].
Eye health
against eye-related macular degeneration (the most
conditions. Astaxanthin protects the eye against eye
fatigue, improves visual activity and depth percep-
Astaxanthin does this because it crosses the
blood–retinal barrier; hence, protecting the eyes.
These antioxidant properties have protective
effects on the eyes, protecting it against cataract,
macular degeneration, and even blindness. Iwasaki
and Tahara [34] concluded that astaxanthin
reduces cataract formation, glaucoma, and macular
degeneration.
Prevenon of complicaons of diabetes mellitus
In 2015, a meta-analysis of data from 10 random-
supplementation with astaxanthin on plasma lipid
involving db/db mice, prevention of diabetic
nephropathy was noted on treatment with astaxan-
thin. It is found that chronic administration of astax-
anthin reduces the oxidative stress on the kidneys
and prevents renal cell damage. A dose of 6.8 mg
a day decreased the level of blood glucose [35–37].
Uchiyama et al. [38] and Ambati et al. [39] noted
that giving astaxanthin to obese or/and diabetic
animals experienced lower plasma glucose levels,
-
mation and oxidative stress. In addition, astaxan-
thin enhanced the ability of the pancreas to secrete
insulin and slowed down the rate of diabetic
nephropathy [27,38,39].
Brain health/stroke/hypertension prevenon
been noted in experimental animals. It is known
to protect against stroke and hypertension and in
improving memory in vascular dementia [40–43].
Astaxanthin crosses the blood–brain barrier; hence,
protecting the brain [42]. At a given dose of 6–8 mg
daily, there was a reduction in blood pressure in
-
erties of the marine carotenoid, astaxanthin and
omega-3-fatty acid, are seen as prospective future
combinations [44]. Fassett et al. further noted that
astaxanthin protects against aging and improves
mental functions in rats, 50 mg/kg astaxanthin oil
reduced both systolic and diastolic blood pressure
in spontaneously hypertensive rats/mrc-cp rats (a
model for metabolic syndrome) [45].
Sports-related acvies
Astaxanthin is known to promote muscle endur-
ance and protects against muscle damage [46,47].
Astaxanthin limits exercise-induced skeletal mus-
cle damage in mice. It is now used by athletes to
enhance performance. The same properties that it
4 J Mol Pathophysiol • 2018 • Vol 7 • Issue 1
Lawson Ekpe, Kenneth Inaku, Victor Ekpe
supported [47–49]. This it does by reducing the pro-
duction and storage of lactic acid, reducing free rad-
ical, and supporting mitochondrial function [50].
Skin health
improves skin elasticity, protects against sun dam-
age, and prevents age spots and hyperpigmentation.
Astaxanthin works as an internal sunscreen of the
damage to skin cells [51]. It is a potent UV radiation
absorber [27]. Tominaga et al. in a study involving
38 healthy females gave 6 mg/day of astaxanthin
oral supplement and 2 ml/day topical astaxanthin
to the participating subjects. Their results showed
that the H. pluvialis-derived astaxanthin improved
skin conditions in all layers such as corneocyte
layer, epidermis, basal and dermis layer by combin-
ing oral and topical treatment [52]. Astaxanthin is
believed to offer skin protection through a number
of mechanisms. First, it is believed to block a cer-
tain amount of the UV radiation acting directly on
the skin. Secondly, it neutralizes the free radicals
induced by the UV radiation. Thirdly, it appears to
inhibit the induction of matrix metalloproteinase
(MMP) by UV light. MMP is thought to be an import-
ant factor in sun damage and skin aging [53]. In yet
another study in 1998, Savoure et al. also noted
that astaxanthin, when given alone or in combina-
tion with retinol, substantially reduced/prevented
photo-aging of the skin. This study in rats also
showed that astaxanthin was found to be 100 times
stronger than beta-carotene and 1,000 times stron-
ger than lutein in preventing UV light-induced oxi-
dative stress [54].
Pepc ulcer disease prevenon
The ulcer-preventing ability was studied in
India when researchers [55,56] at Central Food
Technological Institute gave carotenoids and
astaxanthin esters orally at doses of 100, 250, and
5,000 mcg/kg to rats. After being fed antioxidants,
ethanol was then given to induce gastric ulcer in the
studied rats. The researchers noted that lipoxygen-
ase inhibitors in the rat cells were 23 times greater
when astaxanthin was given compared to admin-
istration of omeprazole, a proton-pump inhibitor
used for peptic ulcer disease management. They
concluded that free radicals scavenging activity of
astaxanthin found in H. pluvialis protects against
gastric mucosal injury [27,55,56].
Lipid peroxidaon/atherosclerosis prevenon
Astaxanthin is thought to inhibit lipid peroxidation
and simultaneously simulate cancer cells, making
it effective for treating breast, colon, and bladder
cancers. Also, astaxanthin reduces C-reactive pro-
tein in the cardiovascular system, reducing tri-
glycerides, increasing high-density lipoprotein
cholesterol and adiponectin levels. In another
study done in Finland, Karppi et al. assessed the
effect of 3-month astaxanthin supplementation
on certain healthy non-smokers aged between
19 and 33 years. The intervention group received
two 4 mg capsules daily while the control received
-
mentation with astaxanthin decreased the in vivo
oxidation of fatty acids in the healthy men [57]. In
another study by Jacobsson et al. [58], taking 6–8
mg daily of astaxanthin decreased the oxidation of
low-density lipoprotein cholesterol and prevented
it from atherogenic effect. It protects the vascular
-
tects cholesterol from being oxidized. Astaxanthin
is thought to play a role in atherosclerosis preven-
effects in endothelial cells. Dysfunction of both
systems in these cells produces a pro-atherogenic
state [17,45,59].
Conclusion
From its discovery till now, astaxanthin has been
found to be a useful antioxidant which has the
potential of mopping up free radicals. The chemical
structure of astaxanthin makes it an excellent anti-
oxidant. This single property has been found to be
from free radical scavenging, mitochondrial protec-
glycation [60,61].
With the advancement in technology, synthetic
production of astaxanthin by genetic engineering
will go a long way in supplying the needed astax-
anthin in both agricultural and medical uses. It is
believed that the extraction of astaxanthin from
its natural sources and synthetic-based forms will
play a great role in the management of patients
humans.
Conict of interest
www.jmolpat.com 5
Astaxanthin as an anoxidant
References
[1] Bolarin DM, Ekpe EL, Saidu KS, Eyam SE. Overview
of foods with antioxidant effects-clinical relevance.
Eur J Food Sci Technol 2016; 4(2):1–9.
Pharmacogn Rev 2010; 4(8):118–26.
[3] Shanon R, Stepan M, Timothy AT, Oleksandra P,
Seidel L. Intracellular and extracellular Redox
states and free radical generation in primary
immune cells from children with austism. Autism
Res Treat 2012; 986519:1–10.
[4] Caraceni P, Ryu HS, van Thiel D, Borle AB. Sources
of oxygen free radicals produced by rat hepatocytes
during postanoxis reoxygenation. Mol Cell Res
1995; 1268(3):249–54.
[6] Flaman Z, Pellachia-Clarke S, McGuigan M, Bailey B.
Unintentional exposure of young children to cam-
phor and eucalyptus oils. Paediatr Child Health
2001; 6(2):80–3.
[7] Shahihi F, Zhong YL. Measurement of antioxidant
activity. J Function Food 2015; 18(Part B):757–81.
and their reaction mechanisms. RSC Adv 2015;
5:27986–8006.
[9] Dizdaroglu M, Faruga P. Mechanism of free
2012; 46:382–419.
[10] Astaxanthin. Available via https://en.wikipedia.
org/wiki/Astaxanthin
keto-carotenoids canthaxanthin, astaxanthin, and
astacene. J Organ Chem 70(8):3328–31.
[12] Astaxanthin. Available via https://pubchem.ncbi.
nlm.nih.gov/compound/Astaxanthin#section=Top
(Accessed 18 April 2018).
[13] What is astaxanthin? Availabale via http://
astaxanthin.org/about/what-is-astaxanthin/
(Accessed 18 April 2018).
[14] Cooper RDG, Davis JB, Leftwick AP, Price C, Weedon
B. Carotenoids and related compounds. XXXII.
Synthesis of astaxanthin, hoenicoxanthin, hydroxye-
chinenone, and the corresponding diosphenols. J
Chem Soc Perkin Trans 1975; 1(21):2195–204
[15] Astaxanthin antioxidant. Available via https://
astaxanthin-antioxidant.blogspot.com.ng/2017/04/
astaxanthin-and-obesity.html (Accessed 18 April
2018).
[16] Du P, Jin M, Yang L, Chen G, Zhan C, Jin F.
Determination of astaxanthin in feeds using high
-
cient extraction method. J Chromatogr 2016;
39(1):35–43.
[17] Lim KC, Yussoff FM, Shariff M, Kamarudin MS.
Astaxanthin as feed supplement in aquatic animals.
Rev Aquacult 2017; doi:10.1111/raq.12200.
[18] Lee CS, Choi YE, Yun YS. Strategy for promoting
astaxanthin accumulation in Haemococcus pluvialis
by 1-aminocyclopropane-1carboxylic acid applica-
tion. J Biotechnol 2016; 236:120–7.
[19] Shang M, Ding W, Zhao Y. Enhanced astaxan-
thin production from H. pluvialis using butylated
hydroxylanisole. J Biotechnol 2016; 236:197–207.
[20] Pashkow FJ, Watumull DG, Campbell CL.
Astaxanthin: a novel potential treatment for oxida-
-
eases. Am J Cardiol 2008; 101:58D–68D.
[21] Komatsu T, Sasaki S, Manabe Y, Hirata T, Sugawara T.
Preventive effect of dietary astaxanthin on UVA-
induced skin photoaging in hairless mice. PLoS One
2017; 12(2):e0171178.
[22] Ambati RR, Moi PS, Ravi S, Aswathanarayana RG.
Astaxanthin: sources, extraction, stability, biolog-
ical activities and commercial applications. Mar
Drugs 2014; 12(1):128–52.
mechanisms of astaxanthin: a potential therapeu-
tic role in preserving cognitive function in age and
neuro-degeneration. Geoscience 2017; 39(1):19–32.
Tsutsui A. Astaxanthin prevents and reverses diet-in-
duced insulin resistance and steatohepatitis in mice:
a comparison with vitamin E. Sci Rep 2015; 5:17192.
[25] Fassett RG, Coombes JS. Astaxanthin in cardio-
vascular health and diseases. Molecules 2012;
17(2):2030–48.
[26] Kidd P. Astaxanthin- cell membrane and nutri-
potentials. Altern Med Rev 2011; 16(4):255–64.
[27] Beutner S, Bloedorn B, Frixel S, Hernández Blanco I,
Hoffmann T, Martin H-D, et al. Quantitative assess-
ment of antioxidant properties of natural colorants
-
-
idant functions. J Sci Food Agric 2001; 81:559–68;
doi:10.1002/jsfa.849
[28] Palozza P, Torrelli C, Boninsegna A. Growth inhib-
itory effects of the astaxanthin-rich H. pluvialis
in human colon cancer cell. Cancer Lett 2009;
283(1):108–17.
inhibits tumor invasion by decreasing extracellular
matrix pollution and induces apoptosis in exper-
imental rat colon carcinogenesis by modulating
effects. Availabale via http://www.raysahelian.
com/astaxanthin.html (Accessed 18 April 2018).
[31] Zhang L, Wang H. Multiple mechanisms of
anti-cancer effects exerted by astaxanthin. Mar
Drug 2015; 13(7):4310–30.
[32] Camera E, Mastrofrancesco A, Fabbri C, Daubrawa F,
Picardo M, Sies H. Astaxanthin, canthaxanthin and
6 J Mol Pathophysiol • 2018 • Vol 7 • Issue 1
Lawson Ekpe, Kenneth Inaku, Victor Ekpe
damage and expression of oxidative stress-responsive
enzymes. Exp Dermatol 2009; 18(3):222–31;
doi:10.1111/j.1600-0625.2008.00 790
[33] Santocomo M, Zurria M, Berrettini M, Fedeli D,
Falcioni G. Lutein, zeaxanthin and astaxanthin pro-
-
roblastoma cells induced by reactive nitrogen spe-
cies. J Photochem Photobiol B 2007; 88(1):1–10;
doi:10.1016/j.jphotobiol.2007.04.007
[34] Iwasaki T, Tahara A. Effects of astaxanthin on eye
strain induced by accommodative dysfunction. J
Eye 2006; 23(6):829–34.
nephropathy by treatment with astaxanthin in dia-
betic db/db mice. Biofactors 2004; 20(1):49–53.
mesangial cells from hypoglycemia- induced oxida-
tive signaling. J Cell Biochem 2008; 103(6):1925–37.
[37] Astaxanthin may protect against the onset and pro-
gression of kidney damage associated with type
2 diabetes mellitus. Available via http://www.
fujichemical.co.jp/english/newsletter/newsletter_
nutra_0803.html (Accessed 18 April 2018).
Takahashi J, Yoshikawa T. Astaxanthin protects
beta cells against glucose toxicity in diabetic db/db
mice. Redox Rep 2002; 7(5):290–3.
[39] Ambati RR, Moi PS, Ravi S, Aswuthnagama G.
Astaxanthin, sources, extinction, stability, biolog-
ical activities and in commercial application—a
review. Mar Drugs 2014; 12(1):128–52.
-
tial neuro-protective agent for neurological dis-
eases. Mar Drugs 2015; 13(90):5750–66.
Sankara U. Anti- hypertensive and neuro-protective
effects of astaxanthin in experimental animals. Biol
Pharm Bull 2005; 28(1):47–52.
[42] Manabe Y, Komatsu T, Seki S, Sugawara T. Dietary
astaxanthin can accumulate in the brain of rats.
Biosci Biotechnol Biochem 2018; 82(8):1433–6.
[43] Bahonar A. Carotenoids as potential antioxidant
agents in stroke prevention: a systemic review. Int J
Pre Med 2017; 8:70.
[44] Fassett RG, Coombes JS. Astaxanthin, oxidative
Fut Cardiol 2009; 5(3):333–42.
effects of astaxanthin. Integr Blood Press Control
2008; 1:1–3.
[46] Ikeuchi M, Koyama T, Takahashi J, Yazawu K.
Effects of astaxanthin supplementation on exer-
cise-induced fatigue in mice. Biol Pharm 2006;
29(10):2106–10.
[47] Astaxanthin supports eye, skin, joints, heart and
exercise recovery. Available via https://www.
nutritionexpress.com/supplements/astaxanthin
(Accessed 18 April 2018).
[48] Djordjevic B, Baralic I, Kotur-Stevuljevic C,
Stefanovic A, Ivanisevic J. Effect of astaxanthin
supplementation on muscle damage and oxida-
tive stress markers in elite young soccer players. J
Sports Med Phys Fitness 2012; 52(4):382–92.
[49] Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects
of astaxanthin supplementation on exercise-in-
duced fatigue in mice. Biol Pharm Bull 2006;
29(10):2106–10.
Maoka T, et al. Astaxanthin limits exercise-in-
duced skeletal and cardiac muscle damage in mice.
Antioxid Redox Signal 2003; 5(1):139–44.
[51] Hama S, Takahasi IY. Protective effects of topical
application of poorly soluble antioxidant astaxan-
thin liposomal formulation on ultraviolet-induced
skin damage. J Pharm Sci 2012; 101(8):2909–16.
-
jects. Acta Biochim Pol 2012; 59(1):43–7.
[53] Kumi A. Effect of antioxidant to inhibit UV-induced
wrinkles. J Japan Cosmet Sci Soc 2003;
27(4):298–303.
Maudati M. Vitamin A status and metabolism of
cutaneous polyamines in hairless mouse after UV
irradiation: action of beta carotene and astaxan-
[55] Kamath BS, Srikanta BM, Dharmesh SM, Sarada R,
Ravishankar GA. Ulcer-preventive and antioxida-
tive properties of astaxanthin from Haematocuccus
pluvialis. Eur J Pharmacol 2008; 590(1–3):387–95.
[56] Kamath BS, Srinkata BM, Dharmesh SM, Sarada R,
Ravishankar VA. Ulcer preventive and anti-oxidative
properties of astaxanthin from Haematococcus plu-
vialis. Eur J Pharm 2008; 590(1–3):387–95.
Effects of astaxanthin supplementation on lipid
[58] Jacobsson S, Yuan XM, Zieden B, Olsson AG. Effects
of alpha tocopherol and astaxanthin in low den-
sity lipoprotein cholesterol-oxidation and athero-
sclerosis in WHHL rabbits. Atherosclerosis 2004;
173(2):231–7.
[59] Lee PH, Kim CS, Lee YJ. Astaxanthin protects against
MPTP/MPP-induced mitochondrial dysfunction
and ROS population in vivo and in vitro. Food Chem
Toxicol 2011; 49(1):271–80.
[60] Wolf AM, Assoh S, Hirauna H. Astaxanthin protects
mitochondrial redox state and functional integ-
21(5):389–91.
[61] Higuera CI, Felix-Valenzuela F, Goycoolea FM.
Astaxanthin: a review of its chemistry and applica-